Diagnosis and Management of Gestational Trophoblastic Neoplasia

[1]  R. Berkowitz,et al.  Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. , 2014, The Journal of reproductive medicine.

[2]  N. Sebire,et al.  EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  F. Sweep,et al.  Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia. , 2012, Gynecologic oncology.

[4]  R. Berkowitz,et al.  Current management of gestational trophoblastic neoplasia. , 2012, Hematology/oncology clinics of North America.

[5]  J. Lurain.  Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. , 2010, American journal of obstetrics and gynecology.

[6]  Neil J Sebire,et al.  Gestational trophoblastic disease , 2010, The Lancet.

[7]  K. Morris.  Terje Pedersen: a pioneer trialist in preventive cardiology , 2010, The Lancet.

[8]  M. Seckl,et al.  The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l−1 , 2010, British Journal of Cancer.

[9]  N. Sebire,et al.  Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study , 2009, The Lancet.

[10]  R. Berkowitz,et al.  Molar pregnancy: pathology and management , 2008 .

[11]  M. Wells,et al.  Epithelioid trophoblastic tumor: a review of the literature. , 2008, The Journal of reproductive medicine.

[12]  A. Lim,et al.  Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour. , 2007, The Lancet. Oncology.

[13]  X. Wan,et al.  Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP‐EMA) regimen , 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[14]  X. Xie,et al.  EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients , 2007, International Journal of Gynecologic Cancer.

[15]  L. Cole,et al.  Normal production of human chorionic gonadotropin in menopause. , 2007, The New England journal of medicine.

[16]  T. Powles,et al.  A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia , 2007, British Journal of Cancer.

[17]  Rochelle L. Garcia,et al.  Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast. , 2006, Archives of pathology & laboratory medicine.

[18]  N. Sebire,et al.  Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia. , 2006, The Journal of reproductive medicine.

[19]  B. Hancock.  hCG measurement in gestational trophoblastic neoplasia: a critical appraisal. , 2006, The Journal of reproductive medicine.

[20]  L. Cole,et al.  The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers. , 2006, The Journal of reproductive medicine.

[21]  J. Schink,et al.  Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. , 2006, The Journal of reproductive medicine.

[22]  L. Cole,et al.  Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin. , 2006, The Journal of reproductive medicine.

[23]  R. Berkowitz,et al.  Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. , 2006, Gynecologic oncology.

[24]  G. Tomlinson,et al.  Sonographic Diagnosis of Gestational Trophoblastic Disease and Comparison With Retained Products of Conception , 2006, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[25]  R. Scully,et al.  Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance. , 2006, Gynecologic oncology.

[26]  G. Tulunay,et al.  Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia , 2005, International Journal of Gynecologic Cancer.

[27]  M. Wells,et al.  Placental site trophoblastic tumour: clinical features and management. , 2005, Gynecologic oncology.

[28]  C. Sweep,et al.  The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. , 2005, Gynecologic oncology.

[29]  J. Lurain,et al.  Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. , 2005, Gynecologic oncology.

[30]  A. Mitsuhashi,et al.  Early pregnancy outcomes after chemotherapy for gestational trophoblastic tumor. , 2004, The Journal of reproductive medicine.

[31]  B. Hancock,et al.  Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases. , 2004, The Journal of reproductive medicine.

[32]  E. Kohorn.  What we know about low-level hCG: definition, classification and management. , 2004, The Journal of reproductive medicine.

[33]  R. Berkowitz,et al.  Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia. , 2004, The Journal of reproductive medicine.

[34]  J. Soper.  Role of surgery and radiation therapy in the management of gestational trophoblastic disease. , 2003, Best practice & research. Clinical obstetrics & gynaecology.

[35]  C. Key,et al.  Trends in Gestational Choriocarcinoma: A 27‐Year Perspective , 2003, Obstetrics and gynecology.

[36]  J. Lurain.  Pharmacotherapy of gestational trophoblastic disease , 2003, Expert opinion on pharmacotherapy.

[37]  H. Smith.  Gestational trophoblastic disease epidemiology and trends. , 2003, Clinical obstetrics and gynecology.

[38]  D. Wendling,et al.  Recent progress in ankylosing spondylitis treatment , 2003, Expert opinion on pharmacotherapy.

[39]  E. Kohorn.  Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report. , 2002, The Journal of reproductive medicine.

[40]  G. Rustin,et al.  Management of brain metastases in patients with high-risk gestational trophoblastic tumors. , 2002, The Journal of reproductive medicine.

[41]  I. McNeish,et al.  Twenty-five years' clinical experience with placental site trophoblastic tumors. , 2002, The Journal of reproductive medicine.

[42]  R. Berkowitz,et al.  Quality of life after gestational trophoblastic disease. , 2002, The Journal of reproductive medicine.

[43]  R. Berkowitz,et al.  Advances in the understanding of placental site trophoblastic tumor. , 2002, The Journal of reproductive medicine.

[44]  E. Kohorn.  Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance? , 2002, Gynecologic oncology.

[45]  M. Seckl,et al.  The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours , 2002, British Journal of Cancer.

[46]  N. Sebire,et al.  Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age , 2002, BJOG : an international journal of obstetrics and gynaecology.

[47]  M. Seckl,et al.  Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  R. Berkowitz,et al.  CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor. , 2000, The Journal of reproductive medicine.

[49]  I. Shih,et al.  Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. , 1998, The American journal of surgical pathology.

[50]  S. J. Kim,et al.  Subsequent reproductive experience after treatment for gestational trophoblastic disease. , 1998, Gynecologic oncology.

[51]  R. Berkowitz,et al.  Gestational Trophoblastic Disease , 1998, Clinical obstetrics and gynecology.

[52]  R. Woolas,et al.  Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome , 1998, British journal of obstetrics and gynaecology.

[53]  E S Newlands,et al.  EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  C. Verschraegen,et al.  Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue. , 1997, Gynecologic oncology.

[55]  E. Newlands,et al.  Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  M. J. Webb,et al.  TREATMENT OF PLACENTAL SITE TROPHOBLASTIC TUMOR WITH HYSTEROTOMY AND UTERINE RECONSTRUCTION , 1996, Obstetrics and gynecology.

[57]  P. Giacalone,et al.  High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease. , 1995, Gynecologic oncology.

[58]  J. Palmer,et al.  Advances in the epidemiology of gestational trophoblastic disease. , 1994, The Journal of reproductive medicine.

[59]  R. Berkowitz,et al.  Brain metastases of gestational trophoblastic tumor. , 1992, The Journal of reproductive medicine.

[60]  R. Berkowitz,et al.  A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. , 1992, Obstetrics and gynecology.

[61]  C. la Vecchia,et al.  Risk Factors for Gestational Trophoblastic Disease: A Separate Analysis of Complete and Partial Hydatidiform Moles , 1991, Obstetrics and gynecology.

[62]  R. Fisher,et al.  A prospective genetic study of complete and partial hydatidiform moles. , 1991, American journal of obstetrics and gynecology.

[63]  D. Mutch,et al.  Recurrent gestational trophoblastic disease. Experience of the southeastern regional trophoblastic disease center , 1990, Cancer.

[64]  A. Ayhan,et al.  Pregnancy after chemotherapy for gestational trophoblastic disease. , 1990, The Journal of reproductive medicine.

[65]  M. Bracken.  Incidence and aetiology of hydatidiform mole: an epidemiological review , 1987 .

[66]  S. Takeuchi,et al.  Incidence of gestational trophoblastic disease by regional registration in Japan. , 1987, Human reproduction.

[67]  K. Bagshawe,et al.  HYDATIDIFORM MOLE IN ENGLAND AND WALES 1973-83 , 1986, The Lancet.

[68]  H Fox,et al.  Pathology of the placenta. , 1986, Major problems in pathology.

[69]  M. Bracken,et al.  Choriocarcinoma incidence in the United States. , 1986, American journal of epidemiology.

[70]  D. Grimes,et al.  Epidemiology of hydatidiform mole during early gestation. , 1986, American journal of obstetrics and gynecology.

[71]  R. Berkowitz,et al.  Risk factors for complete molar pregnancy from a case-control study. , 1985, American journal of obstetrics and gynecology.

[72]  N. Wake,et al.  Human lymphocyte antigen expression in hydatidiform mole: Androgenesis following fertilization by a haploid sperm , 1979 .

[73]  U. Surti,et al.  The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. , 1978, American journal of obstetrics and gynecology.

[74]  K. Ohama,et al.  Androgenetic origin of hydatidiform mole , 1977, Nature.

[75]  K. Bagshawe,et al.  Immunodiagnosis and monitoring of gonadotrophin‐producing metastases in the central nervous system , 1976, Cancer.

[76]  A. Webster,et al.  Gestational trophoblastic disease. A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma. , 1971, American journal of obstetrics and gynecology.

[77]  J. Lewis,et al.  Five year's experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. , 1961, American journal of obstetrics and gynecology.

[78]  J. Lurain.  Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. , 2011, American journal of obstetrics and gynecology.

[79]  L. Cole,et al.  Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases. , 2010, Gynecologic oncology.

[80]  R. Berkowitz,et al.  The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. , 2005, Gynecologic oncology.

[81]  R. A. Fisher,et al.  Gestational trophoblastic disease. Molecular and genetic studies. , 1998, The Journal of reproductive medicine.

[82]  R. Berkowitz,et al.  Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. , 1998, The Journal of reproductive medicine.

[83]  T. Kameda,et al.  Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole. , 1991, Gynecologic oncology.

[84]  R. Berkowitz,et al.  Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors. , 1990, Gynecologic oncology.

[85]  C. la Vecchia,et al.  Dietary factors and risk of trophoblastic disease. , 1988, American journal of obstetrics and gynecology.

[86]  M. Weinbren,et al.  Test for beta-lactamase production. , 1985, Lancet.